DENTSPLY SIRONA (XRAY) SVP receives 9,599-share stock award in Form 4

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Johnson Robert Anthony reported acquisition or exercise transactions in this Form 4 filing.

DENTSPLY SIRONA Inc. senior vice president Robert Anthony Johnson reported an award of 9,599 shares of common stock at no cost, increasing his directly held stake to 125,912.146 shares. The filing also notes that performance criteria for 1,478 performance-based restricted stock units granted on March 3, 2023 were certified as attained on March 2, 2026, with those units scheduled to vest into common shares on March 3, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Johnson Robert Anthony

Role SVP, Chief Supply Chain Office

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,599	$0.00	--

Holdings After Transaction: Common Stock — 125,912.146 shares (Direct)

Footnotes (1)

[object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/03/2026 - 05:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Robert Anthony

(Last)

(First)

(Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE

28222

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Chief Supply Chain Office

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/02/2026		A		9,599⁽¹⁾	A	$0	125,912.146	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On March 3, 2023, the Reporting Person was granted performance-based restricted stock units ("PRSUs"). Each PRSU represents a contingent right to receive a share of the Issuer's Common Stock upon settlement. The Compensation Committee of the Issuer's Board of Directors certifies attainment based on the Issuer's satisfaction of certain performance criteria. The performance criteria were met and 1,478 PRSUs were certified as attained on March 2, 2026. The PRSUs vest and become shares of the Issuer's Common Stock on March 3, 2026.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Robert Anthony Johnson	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did XRAY executive Robert Anthony Johnson report?

Robert Anthony Johnson reported receiving 9,599 shares of DENTSPLY SIRONA common stock as a grant or award at no cost. This transaction reflects equity-based compensation rather than an open-market purchase and increased his directly held ownership in the company.

How many DENTSPLY SIRONA (XRAY) shares does Robert Anthony Johnson now hold?

After the reported grant, Robert Anthony Johnson directly holds 125,912.146 shares of DENTSPLY SIRONA common stock. This figure represents his post-transaction ownership as disclosed, reflecting the addition of 9,599 awarded shares to his existing stake.

Was the XRAY insider transaction a stock purchase or an award?

The XRAY insider transaction was an award, not a purchase. Robert Anthony Johnson acquired 9,599 shares of common stock at a price of $0.0000 per share, indicating a grant or compensation-related issuance rather than a market buy transaction.

What performance-based restricted stock units (PRSUs) are mentioned for XRAY?

On March 3, 2023, Robert Anthony Johnson was granted performance-based restricted stock units, each representing a contingent right to one common share. The compensation committee certified that performance criteria were met for 1,478 PRSUs on March 2, 2026, triggering future vesting.

When will the certified XRAY PRSUs vest into common stock?

The 1,478 performance-based restricted stock units certified as attained will vest and convert into shares of DENTSPLY SIRONA common stock on March 3, 2026. Vesting follows satisfaction of specified performance criteria overseen by the company’s compensation committee.

What role does Robert Anthony Johnson hold at DENTSPLY SIRONA (XRAY)?

Robert Anthony Johnson serves as Senior Vice President and Chief Supply Chain Officer at DENTSPLY SIRONA. The reported stock grant and performance-based restricted stock units represent part of his equity compensation in this executive leadership role.